CRY2 and neoplasm: The transfection of mCh‐NanoLuc‐CRY2 alone did not cause cell death within 30 min after Fz treatment (Figure S3e, Supporting Information), fully demonstrating the general applicability of LiPOP1‐NanoLuc for tumor killing in vitro.